12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
This is a 12-week study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of oral CS-0777 in patients with Multiple Sclerosis.
Epistemonikos ID: 908f96dc1f6bfd7ed399a698e1ab8eff8397d1c1
First added on: May 04, 2024